As per our collaborative publication in the American Journal of Infection Control, the scientific community now has access to the findings of inactivation of an Anthrax surrogate (Bacillis subtilis). This work was completed in our University of Colorado Boulder laboratory. The ability to kill this relative resistant microbe, Bacillis subtilis, is significant as a robust indicator organism: that is, once that threshold is met, it’s generally accepted that such a technology could inactivate most other bacteria and virus particles.
St. Mary’s Hospital for Children (Bayside, NY) is a unique Healthcare Institution that always keeps its focus on the health and well being of their children. As a progressive institution, St. Mary’s is always looking for next generation technology to assist in prevention and reduction of Hospital Acquired Infections or HAI’s. With the focus on reducing airborne caused HAI’s, St. Mary’s deployed SecureAire Technology in early February of 2019 and quickly noticed a significant reduction of HAI’s during the first 60 days by nearly 63%. As the overall trend of HAI’s continued to decrease, the global pandemic of COVID-19 hit the United States with New York being the first “hot spot”. With aggressive measures now enacted by St. Mary’s, and the SecureAire System working continuously during the last 16 months, the outcome for the children and their families has been extraordinary.
I am a grandmother of four, including two sets of twins, ages 5 and 9, who attend grammar school. They live very nearby and visit often. As we all know, when school-age children visit, they often bring with them colds, viruses, and bacteria they have picked up at school. This has frequently impacted my health. Over the last several years, I’ve been sick every couple of months with bronchial infections that have knocked me down for at least a month at a time and required one or more courses of antibiotics to recover.
